lamivudine has been researched along with Rhabdomyolysis in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 3 (50.00) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Casado-Castillo, F; Kelly, P; Saad, M | 1 |
Imoto, S; Kim, SK; Kim, SR; Otono, Y; Tamura, T; Tohyama, M | 1 |
Mano, Y; Shimosegawa, T; Ueno, Y; Yahagi, K | 1 |
Adani, GL; Baccarani, U; Bresadola, F; Della Rocca, G; Risaliti, A; Viale, P | 1 |
Mendila, M; Schmidt, RE; Stoll, M; Walter, GF | 1 |
6 other study(ies) available for lamivudine and Rhabdomyolysis
Article | Year |
---|---|
Case report of Triumeq (abacavir/dolutegravir/lamivudine) associated rhabdomyolysis in a human immunodeficiency virus (HIV) infected patient.
Topics: Anti-HIV Agents; Dideoxynucleosides; Drug Combinations; Heterocyclic Compounds, 3-Ring; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Rhabdomyolysis | 2019 |
Rhabdomyolysis due to lamivudine re-administration in a patient with HBV-related hepatic failure caused by interruption of lamivudine and adefovir.
Topics: Adenine; Antiviral Agents; Drug Administration Schedule; Drug Therapy, Combination; Hepatitis B, Chronic; Humans; Lamivudine; Liver Failure; Male; Medication Adherence; Middle Aged; Organophosphonates; Rhabdomyolysis | 2015 |
Rhabdomyolytic syndrome during the lamivudine therapy for acute exacerbation of chronic type B hepatitis.
Topics: Disease Progression; Hepatitis B, Chronic; Humans; Lamivudine; Liver Transplantation; Reverse Transcriptase Inhibitors; Rhabdomyolysis; Waiting Lists | 2002 |
Rhabdomyolysis due to Lamivudine administration in a liver transplant recipient.
Topics: Antiviral Agents; Hepatitis B; Humans; Lamivudine; Liver Transplantation; Male; Middle Aged; Rhabdomyolysis | 2005 |
[Rhabdomyolysis in antiretroviral therapy with Lamivudin].
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Creatine Kinase; Humans; Lamivudine; Male; Myoglobin; Rhabdomyolysis | 1997 |
Serious adverse events attributed to nevirapine regimens for postexposure prophylaxis after HIV exposures--worldwide, 1997-2000.
Topics: Adult; Anti-HIV Agents; Chemical and Drug Induced Liver Injury; Drug Eruptions; Female; HIV Infections; Humans; Lamivudine; Liver Failure; Male; Nevirapine; Occupational Exposure; Reverse Transcriptase Inhibitors; Rhabdomyolysis; Zidovudine | 2001 |